substance p has been researched along with Heart Defects, Congenital in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bush, A; Collins, P; Kelleher, A; Li, J; Morgan, C; Penny, DJ; Redington, AN; Rigby, ML; Schulze-Neick, I; Shinebourne, EA | 1 |
1 other study(ies) available for substance p and Heart Defects, Congenital
Article | Year |
---|---|
L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.
Topics: Administration, Inhalation; Arginine; Cardiopulmonary Bypass; Endothelium, Vascular; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Infant; Infusions, Intravenous; Nitric Oxide; Oxygen; Postoperative Complications; Pulmonary Circulation; Substance P; Vascular Resistance; Vasodilation; Vasodilator Agents | 1999 |